Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Pharmaceutical Innovations, Inc.
WARNING LETTER
•Pharmaceutical Innovations, Inc.•May 5, 2011

Pharmaceutical Innovations, Inc. – FDA Warning Letter, May 5, 2011

Record Details

This FDA Warning Letter, dated November 21, 2011, addresses Pharmaceutical Innovations, Inc. following an inspection from April 14 to May 5, 2011. The inspection found that the firm's devices, including Ultra Phonic Conductivity Gel and Ultra Phonic Fontanelle Scanning Pad, were adulterated under 21 U.S.C. § 351(h) due to non-conformity with Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part 820).

Key violations include: 1. **Failure to establish and maintain procedures for finished device acceptance (21 CFR 820.80(d))**: Specifically, no documented procedures for final inspection and testing of Ultra Phonic Conductivity Gel for sterility. 2. **Failure to establish and maintain equipment calibration procedures (21 CFR 820.72)**: Dry heat sterilizers used for sterile products were not routinely calibrated, inspected, or maintained. 3. **Failure to identify actions for corrective and preventive action (CAPA) (21 CFR 820.100(a)(3))**: No CAPA initiated for MDR complaint 742 regarding Pseudomonas contamination in ultrasound gel, with the firm's investigation inadequately concluding improper product use without identifying recurrence prevention actions. 4. **Failure to maintain Device Master Records

Company
Pharmaceutical Innovations, Inc.
Inspection date
May 5, 2011
Product type
Devices
Office
New Jersey District Office
People
  • Diana Amador-Toro (District Director)
  • Robert J. Maffei
View Company Profile

ID · f524181a-155f-4cce-87c3-87adc07fbee2

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.80(d)21 CFR 820.7221 CFR 820.100(a)(3)21 CFR 820.18121 CFR 820.18421 CFR 820.30(g)21 CFR 820.70(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmaceutical Innovations, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.